Template:Otitis Externa Antibiotics - Revision history

Danbot: Add pediatric topical dosing

2026-03-20T13:08:35Z

Add pediatric topical dosing

← Revisión anterior		Revisión del 13:08 20 mar 2026
Línea 10:		Línea 10:
	#*Use '''suspension''' (NOT solution) if possibility of perforation		#*Use '''suspension''' (NOT solution) if possibility of perforation
	#*Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking<ref>Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.</ref>		#*Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking<ref>Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.</ref>

			'''Pediatric:'''
			''Same topical regimens apply to children''
			#{{AntibioticDose\|disease=Otitis externa\|drug=Ofloxacin\|dose=5 drops (>12yr) or 3 drops (<12yr) in affected ear BID x 7 days\|context=Pediatric Topical\|population=Pediatric}}
			#{{AntibioticDose\|disease=Otitis externa\|drug=Ciprofloxacin\|dose=3-4 drops in affected ear BID x 7 days\|context=Pediatric Topical\|population=Pediatric}} (with dexamethasone or hydrocortisone)

Danbot: Add disease=Otitis externa parameter to AntibioticDose calls - fixes aggregation page display issue

2026-03-19T23:12:26Z

Add disease=Otitis externa parameter to AntibioticDose calls - fixes aggregation page display issue

← Revisión anterior		Revisión del 23:12 19 mar 2026
Línea 1:		Línea 1:
	#{{AntibioticDose\|drug=Ofloxacin\|dose=5 drops in affected ear BID x 7 days\|context=Topical}} (Floxin otic)<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>		#{{AntibioticDose\|disease=Otitis externa\|drug=Ofloxacin\|dose=5 drops in affected ear BID x 7 days\|context=Topical}} (Floxin otic)<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>
	#*Safe with perforations		#*Safe with perforations
	#{{AntibioticDose\|drug=Ciprofloxacin\|dose=3 drops in affected ear BID x 7 days\|context=Topical (Cipro HC)\|display=Ciprofloxacin-hydrocortisone}}		#{{AntibioticDose\|disease=Otitis externa\|drug=Ciprofloxacin\|dose=3 drops in affected ear BID x 7 days\|context=Topical (Cipro HC)\|display=Ciprofloxacin-hydrocortisone}}
	#*Contains hydrocortisone to promote faster healing		#*Contains hydrocortisone to promote faster healing
	#*Not recommended for perforation since non-sterile preparation		#*Not recommended for perforation since non-sterile preparation
	#{{AntibioticDose\|drug=Ciprofloxacin\|dose=4 drops in affected ear BID x 7 days\|context=Topical (Ciprodex)\|display=Ciprofloxacin-dexamethasone}}		#{{AntibioticDose\|disease=Otitis externa\|drug=Ciprofloxacin\|dose=4 drops in affected ear BID x 7 days\|context=Topical (Ciprodex)\|display=Ciprofloxacin-dexamethasone}}
	#*Similar to Cipro HC but safe for perforations		#*Similar to Cipro HC but safe for perforations
	#*Often more expensive		#*Often more expensive
	#{{AntibioticDose\|drug=Cortisporin otic\|dose=4 drops in ear TID-QID x 7days\|context=Topical}} (neomycin/polymixin B/hydrocortisone)		#{{AntibioticDose\|disease=Otitis externa\|drug=Cortisporin otic\|dose=4 drops in ear TID-QID x 7days\|context=Topical}} (neomycin/polymixin B/hydrocortisone)
	#*Use '''suspension''' (NOT solution) if possibility of perforation		#*Use '''suspension''' (NOT solution) if possibility of perforation
	#*Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking<ref>Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.</ref>		#*Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking<ref>Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.</ref>

Danbot: Convert to {{AntibioticDose}} for SMW antibiotic-disease linking

2026-03-19T21:02:27Z

Convert to {{AntibioticDose}} for SMW antibiotic-disease linking

← Revisión anterior		Revisión del 21:02 19 mar 2026
Línea 1:		Línea 1:
	#[[Ofloxacin~~]] (Floxin otic):~~ 5 drops in affected ear BID x 7 days<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>		#{{AntibioticDose\|drug=Ofloxacin\|dose=5 drops in affected ear BID x 7 days\|context=Topical}} (Floxin otic)<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>
	#*Safe with perforations		#*Safe with perforations
	#[[Ciprofloxacin\|~~Ciprofloxacin-hydrocortisone]] (Cipro HC):~~ 3 drops in affected ear BID x 7 days		#{{AntibioticDose\|drug=Ciprofloxacin\|dose=3 drops in affected ear BID x 7 days\|context=Topical (Cipro HC)\|display=Ciprofloxacin-hydrocortisone}}
	#*Contains hydrocortisone to promote faster healing		#*Contains hydrocortisone to promote faster healing
	#*Not recommended for perforation since non-sterile preparation		#*Not recommended for perforation since non-sterile preparation
	#[[Ciprofloxacin\|~~Ciprofloxacin-dexamthasone]] (Ciprodex):~~ 4 drops in affected ear BID x 7 days		#{{AntibioticDose\|drug=Ciprofloxacin\|dose=4 drops in affected ear BID x 7 days\|context=Topical (Ciprodex)\|display=Ciprofloxacin-dexamethasone}}
	#*Similar to Cipro HC but safe for perforations		#*Similar to Cipro HC but safe for perforations
	#*Often more expensive		#*Often more expensive
	#[[Cortisporin otic~~]] (neomycin/polymixin B/hydrocortisone):~~ 4 drops in ear TID-QID x 7days		#{{AntibioticDose\|drug=Cortisporin otic\|dose=4 drops in ear TID-QID x 7days\|context=Topical}} (neomycin/polymixin B/hydrocortisone)
	#*Use '''suspension''' (NOT solution) if possibility of perforation		#*Use '''suspension''' (NOT solution) if possibility of perforation
	#*Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking<ref>Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.</ref>		#*Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking<ref>Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.</ref>

Spenceemmett at 17:18, 17 October 2021

2021-10-17T17:18:04Z

← Revisión anterior		Revisión del 17:18 17 oct 2021
Línea 1:		Línea 1:
	#~~'''~~[[Floxin otic~~]]'''~~: 5 drops in affected ear BID x 7 days<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>		#[[Ofloxacin]] (Floxin otic): 5 drops in affected ear BID x 7 days<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>
	#*Safe with perforations		#*Safe with perforations
	#~~'''~~[[Ciprofloxacin\|Cipro HC ~~otic]]'''~~: 3 drops in affected ear BID x 7 days		#[[Ciprofloxacin\|Ciprofloxacin-hydrocortisone]] (Cipro HC): 3 drops in affected ear BID x 7 days
	#*Contains hydrocortisone to promote faster healing		#*Contains hydrocortisone to promote faster healing
	#*Not ~~safe with~~ perforation		#*Not recommended for perforation since non-sterile preparation
	#~~'''~~[[Ciprofloxacin\|~~CiproDex~~]]~~'''~~: 4 drops in affected ear BID x 7 days		#[[Ciprofloxacin\|Ciprofloxacin-dexamthasone]] (Ciprodex): 4 drops in affected ear BID x 7 days
	#*Similar to Cipro HC but ~~contains [[dexamethasone]]~~		#*Similar to Cipro HC but safe for perforations
	#~~'''~~[[Cortisporin otic]]~~'''~~ (neomycin/polymixin B/hydrocortisone)		#*Often more expensive
	#*4 drops in ear TID-QID x 7days		#[[Cortisporin otic]] (neomycin/polymixin B/hydrocortisone): 4 drops in ear TID-QID x 7days
	#*Use '''suspension''' (NOT solution) if ~~possiblity~~ of perforation		#*Use '''suspension''' (NOT solution) if possibility of perforation
	#*Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking<ref>Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.</ref>		#*Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking<ref>Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.</ref>

ClaireLewis at 22:22, 25 August 2019

2019-08-25T22:22:33Z

← Revisión anterior		Revisión del 22:22 25 ago 2019
Línea 1:		Línea 1:
	#'''[[Floxin otic]]''': 5 drops in affected ear BID x 7 days<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>		#'''[[Floxin otic]]''': 5 drops in affected ear BID x 7 days<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>
	#*Safe with perforations		#*Safe with perforations
	#'''[[Cipro HC otic]]''': 3 drops in affected ear BID x 7 days		#'''[[Ciprofloxacin\|Cipro HC otic]]''': 3 drops in affected ear BID x 7 days
	#*Contains hydrocortisone to promote faster healing		#*Contains hydrocortisone to promote faster healing
	#*Not safe with perforation		#*Not safe with perforation
	#'''[[CiproDex]]''': 4 drops in affected ear BID x 7 days		#'''[[Ciprofloxacin\|CiproDex]]''': 4 drops in affected ear BID x 7 days
	#*Similar to Cipro HC but contains [[dexamethasone]]		#*Similar to Cipro HC but contains [[dexamethasone]]
	#'''[[Cortisporin otic]]''' (neomycin/polymixin B/hydrocortisone)		#'''[[Cortisporin otic]]''' (neomycin/polymixin B/hydrocortisone)

Lisayee25 at 08:41, 12 July 2018

2018-07-12T08:41:20Z

← Revisión anterior		Revisión del 08:41 12 jul 2018
Línea 4:		Línea 4:
	#*Contains hydrocortisone to promote faster healing		#*Contains hydrocortisone to promote faster healing
	#*Not safe with perforation		#*Not safe with perforation
	#'''[[CiproDex]]''': 3 drops in affected ear BID x 7 days		#'''[[CiproDex]]''': 4 drops in affected ear BID x 7 days
	#*Similar to Cipro HC but contains [[dexamethasone]]		#*Similar to Cipro HC but contains [[dexamethasone]]
	#'''[[Cortisporin otic]]''' (neomycin/polymixin B/hydrocortisone)		#'''[[Cortisporin otic]]''' (neomycin/polymixin B/hydrocortisone)
	#*4 ~~gtt~~ in ear TID-QID x ~~7dy~~		#*4 drops in ear TID-QID x 7days
	#*Use '''suspension''' (NOT solution) if possiblity of perforation		#*Use '''suspension''' (NOT solution) if possiblity of perforation
	#*Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking<ref>Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.</ref>		#*Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking<ref>Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.</ref>

Rossdonaldson1 at 21:46, 25 June 2018

2018-06-25T21:46:13Z

← Revisión anterior		Revisión del 21:46 25 jun 2018
Línea 1:		Línea 1:
	#'''Floxin ~~Otic~~''': 5 drops in affected ear BID x 7 days<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>		#'''[[Floxin otic]]''': 5 drops in affected ear BID x 7 days<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>
	#*Safe with perforations		#*Safe with perforations
	#'''Cipro HC ~~Otic~~''': 3 drops in affected ear BID x 7 days		#'''[[Cipro HC otic]]''': 3 drops in affected ear BID x 7 days
	#*Contains hydrocortisone to promote faster healing		#*Contains hydrocortisone to promote faster healing
	#*Not safe with perforation		#*Not safe with perforation
	#'''CiproDex''': 3 drops in affected ear BID x 7 days		#'''[[CiproDex]]''': 3 drops in affected ear BID x 7 days
	#*Similar to Cipro HC but contains ~~Dexamethasone~~		#*Similar to Cipro HC but contains [[dexamethasone]]
	~~#*Also not recommended with perforations~~		#'''[[Cortisporin otic]]''' (neomycin/polymixin B/hydrocortisone)
	#'''Cortisporin ~~Otic~~''' (neomycin/polymixin B/hydrocortisone)
	#*4 gtt in ear TID-QID x 7dy		#*4 gtt in ear TID-QID x 7dy
	#*Use '''suspension''' (NOT solution) if possiblity of perforation		#*Use '''suspension''' (NOT solution) if possiblity of perforation
	#*Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking<ref>Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.</ref>		#*Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking<ref>Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.</ref>

Ostermayer at 09:34, 8 July 2016

2016-07-08T09:34:33Z

← Revisión anterior		Revisión del 09:34 8 jul 2016
Línea 10:		Línea 10:
	#*4 gtt in ear TID-QID x 7dy		#*4 gtt in ear TID-QID x 7dy
	#*Use '''suspension''' (NOT solution) if possiblity of perforation		#*Use '''suspension''' (NOT solution) if possiblity of perforation
			#*Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking<ref>Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.</ref>

Rossdonaldson1 at 09:03, 17 July 2015

2015-07-17T09:03:48Z

← Revisión anterior		Revisión del 09:03 17 jul 2015
Línea 8:		Línea 8:
	#*Also not recommended with perforations		#*Also not recommended with perforations
	#'''Cortisporin Otic''' (neomycin/polymixin B/hydrocortisone)		#'''Cortisporin Otic''' (neomycin/polymixin B/hydrocortisone)
	#*4 gtt in ear ~~ITD~~-QID x 7dy		#*4 gtt in ear TID-QID x 7dy
	#*Use '''suspension''' (NOT solution) if possiblity of perforation		#*Use '''suspension''' (NOT solution) if possiblity of perforation

Rossdonaldson1 at 21:52, 1 March 2015

2015-03-01T21:52:28Z

← Revisión anterior		Revisión del 21:52 1 mar 2015
Línea 1:		Línea 1:
	#'''Floxin Otic''': 5 drops in affected ear BID x 7 days<ref>Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161		#'''Floxin Otic''': 5 drops in affected ear BID x 7 days<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>
	DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref>
	#*Safe with perforations		#*Safe with perforations
	#'''Cipro HC Otic''': 3 drops in affected ear BID x 7 days		#'''Cipro HC Otic''': 3 drops in affected ear BID x 7 days